Marc G Leguia1, Ralph G Andrzejak2, Christian Rummel3, Joline M Fan4, Emily A Mirro5, Thomas K Tcheng5, Vikram R Rao4, Maxime O Baud1,6. 1. Sleep-Wake-Epilepsy Center, NeuroTec, Center for Experimental Neurology, Department of Neurology, Inselspital Bern, University Hospital, University of Bern, Bern, Switzerland. 2. Department of Information and Communication Technologies, University Pompeu Fabra, Barcelona, Spain. 3. Support Center for Advanced Neuroimaging, University Institute for Diagnostic and Interventional Neuroradiology, Inselspital Bern, University Hospital, University of Bern, Bern, Switzerland. 4. Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco. 5. NeuroPace Inc, Mountain View, California. 6. Wyss Center for Bio and Neuroengineering, Geneva, Switzerland.
Abstract
Importance: Focal epilepsy is characterized by the cyclical recurrence of seizures, but, to our knowledge, the prevalence and patterns of seizure cycles are unknown. Objective: To establish the prevalence, strength, and temporal patterns of seizure cycles over timescales of hours to years. Design, Setting, and Participants: This retrospective cohort study analyzed data from continuous intracranial electroencephalography (cEEG) and seizure diaries collected between January 19, 2004, and May 18, 2018, with durations up to 10 years. A total of 222 adults with medically refractory focal epilepsy were selected from 256 total participants in a clinical trial of an implanted responsive neurostimulation device. Selection was based on availability of cEEG and/or self-reports of disabling seizures. Exposures: Antiseizure medications and responsive neurostimulation, based on clinical indications. Main Outcomes and Measures: Measures involved (1) self-reported daily seizure counts, (2) cEEG-based hourly counts of electrographic seizures, and (3) detections of interictal epileptiform activity (IEA), which fluctuates in daily (circadian) and multiday (multidien) cycles. Outcomes involved descriptive characteristics of cycles of IEA and seizures: (1) prevalence, defined as the percentage of patients with a given type of seizure cycle; (2) strength, defined as the degree of consistency with which seizures occur at certain phases of an underlying cycle, measured as the phase-locking value (PLV); and (3) seizure chronotypes, defined as patterns in seizure timing evident at the group level. Results: Of the 222 participants, 112 (50%) were male, and the median age was 35 years (range, 18-66 years). The prevalence of circannual (approximately 1 year) seizure cycles was 12% (24 of 194), the prevalence of multidien (approximately weekly to approximately monthly) seizure cycles was 60% (112 of 186), and the prevalence of circadian (approximately 24 hours) seizure cycles was 89% (76 of 85). Strengths of circadian (mean [SD] PLV, 0.34 [0.18]) and multidien (mean [SD] PLV, 0.34 [0.17]) seizure cycles were comparable, whereas circannual seizure cycles were weaker (mean [SD] PLV, 0.17 [0.10]). Across individuals, circadian seizure cycles showed 5 peaks: morning, mid-afternoon, evening, early night, and late night. Multidien cycles of IEA showed peak periodicities centered around 7, 15, 20, and 30 days. Independent of multidien period length, self-reported and electrographic seizures consistently occurred during the days-long rising phase of multidien cycles of IEA. Conclusions and Relevance: Findings in this large cohort establish the high prevalence of plural seizure cycles and help explain the natural variability in seizure timing. The results have the potential to inform the scheduling of diagnostic studies, the delivery of time-varying therapies, and the design of clinical trials in epilepsy.
Importance: Focal epilepsy is characterized by the cyclical recurrence of seizures, but, to our knowledge, the prevalence and patterns of seizure cycles are unknown. Objective: To establish the prevalence, strength, and temporal patterns of seizure cycles over timescales of hours to years. Design, Setting, and Participants: This retrospective cohort study analyzed data from continuous intracranial electroencephalography (cEEG) and seizure diaries collected between January 19, 2004, and May 18, 2018, with durations up to 10 years. A total of 222 adults with medically refractory focal epilepsy were selected from 256 total participants in a clinical trial of an implanted responsive neurostimulation device. Selection was based on availability of cEEG and/or self-reports of disabling seizures. Exposures: Antiseizure medications and responsive neurostimulation, based on clinical indications. Main Outcomes and Measures: Measures involved (1) self-reported daily seizure counts, (2) cEEG-based hourly counts of electrographic seizures, and (3) detections of interictal epileptiform activity (IEA), which fluctuates in daily (circadian) and multiday (multidien) cycles. Outcomes involved descriptive characteristics of cycles of IEA and seizures: (1) prevalence, defined as the percentage of patients with a given type of seizure cycle; (2) strength, defined as the degree of consistency with which seizures occur at certain phases of an underlying cycle, measured as the phase-locking value (PLV); and (3) seizure chronotypes, defined as patterns in seizure timing evident at the group level. Results: Of the 222 participants, 112 (50%) were male, and the median age was 35 years (range, 18-66 years). The prevalence of circannual (approximately 1 year) seizure cycles was 12% (24 of 194), the prevalence of multidien (approximately weekly to approximately monthly) seizure cycles was 60% (112 of 186), and the prevalence of circadian (approximately 24 hours) seizure cycles was 89% (76 of 85). Strengths of circadian (mean [SD] PLV, 0.34 [0.18]) and multidien (mean [SD] PLV, 0.34 [0.17]) seizure cycles were comparable, whereas circannual seizure cycles were weaker (mean [SD] PLV, 0.17 [0.10]). Across individuals, circadian seizure cycles showed 5 peaks: morning, mid-afternoon, evening, early night, and late night. Multidien cycles of IEA showed peak periodicities centered around 7, 15, 20, and 30 days. Independent of multidien period length, self-reported and electrographic seizures consistently occurred during the days-long rising phase of multidien cycles of IEA. Conclusions and Relevance: Findings in this large cohort establish the high prevalence of plural seizure cycles and help explain the natural variability in seizure timing. The results have the potential to inform the scheduling of diagnostic studies, the delivery of time-varying therapies, and the design of clinical trials in epilepsy.
Authors: P Polychronopoulos; A A Argyriou; V Sirrou; V Huliara; M Aplada; P Gourzis; A Economou; E Terzis; E Chroni Journal: Neurology Date: 2006-05-09 Impact factor: 9.910
Authors: Maxime O Baud; Antoine Ghestem; Jean-Jacques Benoliel; Christel Becker; Christophe Bernard Journal: Exp Neurol Date: 2019-02-15 Impact factor: 5.330
Authors: Maxime O Baud; Jonathan K Kleen; Emily A Mirro; Jason C Andrechak; David King-Stephens; Edward F Chang; Vikram R Rao Journal: Nat Commun Date: 2018-01-08 Impact factor: 14.919
Authors: Nicholas M Gregg; Mona Nasseri; Vaclav Kremen; Edward E Patterson; Beverly K Sturges; Timothy J Denison; Benjamin H Brinkmann; Gregory A Worrell Journal: Brain Commun Date: 2020-02-06
Authors: Matias I Maturana; Christian Meisel; Katrina Dell; Philippa J Karoly; Wendyl D'Souza; David B Grayden; Anthony N Burkitt; Premysl Jiruska; Jan Kudlacek; Jaroslav Hlinka; Mark J Cook; Levin Kuhlmann; Dean R Freestone Journal: Nat Commun Date: 2020-05-01 Impact factor: 14.919
Authors: Dileep R Nair; Kenneth D Laxer; Peter B Weber; Anthony M Murro; Yong D Park; Gregory L Barkley; Brien J Smith; Ryder P Gwinn; Michael J Doherty; Katherine H Noe; Richard S Zimmerman; Gregory K Bergey; William S Anderson; Christianne Heck; Charles Y Liu; Ricky W Lee; Toni Sadler; Robert B Duckrow; Lawrence J Hirsch; Robert E Wharen; William Tatum; Shraddha Srinivasan; Guy M McKhann; Mark A Agostini; Andreas V Alexopoulos; Barbara C Jobst; David W Roberts; Vicenta Salanova; Thomas C Witt; Sydney S Cash; Andrew J Cole; Gregory A Worrell; Brian N Lundstrom; Jonathan C Edwards; Jonathan J Halford; David C Spencer; Lia Ernst; Christopher T Skidmore; Michael R Sperling; Ian Miller; Eric B Geller; Michel J Berg; A James Fessler; Paul Rutecki; Alica M Goldman; Eli M Mizrahi; Robert E Gross; Donald C Shields; Theodore H Schwartz; Douglas R Labar; Nathan B Fountain; W Jeff Elias; Piotr W Olejniczak; Nicole R Villemarette-Pittman; Stephan Eisenschenk; Steven N Roper; Jane G Boggs; Tracy A Courtney; Felice T Sun; Cairn G Seale; Kathy L Miller; Tara L Skarpaas; Martha J Morrell Journal: Neurology Date: 2020-07-20 Impact factor: 9.910
Authors: Philippa J Karoly; Dean R Freestone; Dominique Eden; Rachel E Stirling; Lyra Li; Pedro F Vianna; Matias I Maturana; Wendyl J D'Souza; Mark J Cook; Mark P Richardson; Benjamin H Brinkmann; Ewan S Nurse Journal: Front Neurol Date: 2021-08-04 Impact factor: 4.003
Authors: Sharon Chiang; Ankit N Khambhati; Emily T Wang; Marina Vannucci; Edward F Chang; Vikram R Rao Journal: Brain Stimul Date: 2021-02-06 Impact factor: 8.955
Authors: Mayela Zamora; Sebastian Meller; Filip Kajin; James J Sermon; Robert Toth; Moaad Benjaber; Derk-Jan Dijk; Rafal Bogacz; Gregory A Worrell; Antonio Valentin; Benoit Duchet; Holger A Volk; Timothy Denison Journal: Front Neurosci Date: 2021-09-24 Impact factor: 4.677
Authors: Rachel E Stirling; David B Grayden; Wendyl D'Souza; Mark J Cook; Ewan Nurse; Dean R Freestone; Daniel E Payne; Benjamin H Brinkmann; Tal Pal Attia; Pedro F Viana; Mark P Richardson; Philippa J Karoly Journal: Front Neurol Date: 2021-07-15 Impact factor: 4.003